Detalhe da pesquisa
1.
Timing of Biomarker Changes in Sporadic Alzheimer's Disease in Estimated Years from Symptom Onset.
Ann Neurol;
95(5): 951-965, 2024 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38400792
2.
Suvorexant Acutely Decreases Tau Phosphorylation and Aß in the Human CNS.
Ann Neurol;
94(1): 27-40, 2023 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36897120
3.
Change in Cerebrospinal Fluid Tau Microtubule Binding Region Detects Symptom Onset, Cognitive Decline, Tangles, and Atrophy in Dominantly Inherited Alzheimer's Disease.
Ann Neurol;
93(6): 1158-1172, 2023 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36843330
4.
Head-to-head comparison of 10 plasma phospho-tau assays in prodromal Alzheimer's disease.
Brain;
146(4): 1592-1601, 2023 04 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36087307
5.
Acute sleep loss decreases CSF-to-blood clearance of Alzheimer's disease biomarkers.
Alzheimers Dement;
19(7): 3055-3064, 2023 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36695437
6.
CSF tau microtubule binding region identifies tau tangle and clinical stages of Alzheimer's disease.
Brain;
144(2): 515-527, 2021 03 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33283854
7.
Sleep Deprivation Affects Tau Phosphorylation in Human Cerebrospinal Fluid.
Ann Neurol;
87(5): 700-709, 2020 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32057125
8.
Neurofilaments: neurobiological foundations for biomarker applications.
Brain;
143(7): 1975-1998, 2020 07 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32408345
9.
Corrigendum to: CSF tau microtubule binding region identifies tau tangle and clinical stages of Alzheimer's disease.
Brain;
144(9): e82, 2021 Oct 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34215872
10.
Tau Protein Quantification in Human Cerebrospinal Fluid by Targeted Mass Spectrometry at High Sequence Coverage Provides Insights into Its Primary Structure Heterogeneity.
J Proteome Res;
15(2): 667-76, 2016 Feb 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26742856
11.
Disease staging of Alzheimer's disease using a CSF-based biomarker model.
Nat Aging;
4(5): 694-708, 2024 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38514824
12.
Comparison of cerebrospinal fluid, plasma and neuroimaging biomarker utility in Alzheimer's disease.
Brain Commun;
6(2): fcae081, 2024.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38505230
13.
CSF neurofilament light chain profiling and quantitation in neurological diseases.
Brain Commun;
6(3): fcae132, 2024.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38707707
14.
Highly accurate blood test for Alzheimer's disease is similar or superior to clinical cerebrospinal fluid tests.
Nat Med;
30(4): 1085-1095, 2024 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38382645
15.
Mitigating the Associations of Kidney Dysfunction With Blood Biomarkers of Alzheimer Disease by Using Phosphorylated Tau to Total Tau Ratios.
JAMA Neurol;
80(5): 516-522, 2023 05 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36987840
16.
Novel CSF tau biomarkers can be used for disease staging of sporadic Alzheimer's disease.
medRxiv;
2023 Jul 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37503281
17.
CSF tau phosphorylation occupancies at T217 and T205 represent improved biomarkers of amyloid and tau pathology in Alzheimer's disease.
Nat Aging;
3(4): 391-401, 2023 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37117788
18.
CSF MTBR-tau243 is a specific biomarker of tau tangle pathology in Alzheimer's disease.
Nat Med;
29(8): 1954-1963, 2023 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37443334
19.
Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer's disease.
Nat Med;
29(8): 1979-1988, 2023 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37550416
20.
Location of pathogenic variants in PSEN1 impacts progression of cognitive, clinical, and neurodegenerative measures in autosomal-dominant Alzheimer's disease.
Aging Cell;
22(8): e13871, 2023 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37291760